Physician profile
David Hergan
NPI 1912065970
$4,625.20
in general payments reported to CMS, 2019-2025
12 companies · $2,796 in 2025
The $2,796 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $68.36 · 2021: $78.52 · 2022: $316 · 2023: $41.38 · 2024: $194 · 2025: $2,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,849 · Food and Beverage: $1,142 · Gift: $39.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,848.88 |
| Food and Beverage | $1,142.11 |
| Gift | $39.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $2,551.31 | 2025 | Inset System |
| Smith+Nephew, INC. | $1,599.46 | 2019-2025 | Aetos Shoulder System |
| Polaris Technology Solutions LLC | $136.02 | 2024 | |
| Wright Medical Technology, INC. | $61.89 | 2019 | |
| Stryker Corporation | $61.53 | 2021-2023 | Mako |
| Bioventus LLC | $56.46 | 2020-2021 | |
| Davol INC. | $42.57 | 2024 | |
| Vericel Corporation | $36.65 | 2022-2023 | Maci |
| Depuy Synthes Sales INC. | $36.56 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $16.68 | 2019 | |
| Fidia Pharma USA INC. | $14.97 | 2024 | Triluron, Hymovis, Hyalgan |
| Endo Pharmaceuticals INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hergan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.